E. coli strains are good working horses for expressions of recombinant proteins. They have got huge potential for production of low-cost subunit vaccine candidates against various target diseases. However, the presence of E.coli derived endotoxins in the formulation, and expensive cost for their removal from the formulation has become one of the challenges in the bioprocessing of vaccine candidates. Thus, is it possible to engineer E. coli strains that do not produce endotoxins? Did anyone come across such strains?

More Alemu Tekewe Mogus's questions See All
Similar questions and discussions